Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of botulinum toxin type A compared to
placebo control for the treatment of moderate to severe crow's feet lines.
Phase:
Phase 3
Details
Lead Sponsor:
Revance Therapeutics, Inc.
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA